SCHEMBL4635505

SCHEMBL4635505

CCOC(=O)Oc1c(NC(C)=O)nc(N2CCCC(NC(=O)OC(C)(C)C)C2)n1CC=C(C)C

nearest known ligand 0.41

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
BTK Q06187 4/20 0.41
JAK3 P52333 3/20 0.41
MAP4K4 O95819 2/20 0.39
DPP4 P27487 9/20 0.39
LCK P06239 2/20 0.38
EGFR P00533 1/20 0.38
KIF18A Q8NI77 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
PDE10A Q9Y233 1/20 0.36
RET P07949 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4636249 0.92 JAK3 (0.42) BTKJAK3MAP4K4DPP4LCK
SCHEMBL4635283 0.90 MAP4K4 (0.44) BTKJAK3MAP4K4DPP4LCK
SCHEMBL4635245 0.88 BTK (0.41) BTKJAK3MAP4K4DPP4LCK
SCHEMBL3971382 0.88 BTK (0.41) BTKJAK3MAP4K4DPP4LCK
SCHEMBL556256 0.83 BTK (0.41) BTKJAK3MAP4K4DPP4LCK
SCHEMBL554830 0.81 BTK (0.40) BTKJAK3MAP4K4DPP4LCK
SCHEMBL3977507 0.81 BTK (0.43) BTKJAK3MAP4K4DPP4LCK
SCHEMBL556933 0.81 BTK (0.40) BTKJAK3MAP4K4DPP4LCK
SCHEMBL556491 0.81 BTK (0.40) BTKJAK3MAP4K4DPP4LCK
SCHEMBL5437210 0.80 MAP4K4 (0.46) BTKJAK3MAP4K4DPP4LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532150-B1 NOVEL PURINE DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2008-06-11 EP disclosed
EP-1532150-A1 NOVEL PURINE DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-05-25 EP disclosed
WO-2004018469-A1 NOVEL PURINE DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-03-04 WO disclosed